4//SEC Filing
Gault Laura 4
Accession 0001562180-22-007408
CIK 0001597553other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:30 PM ET
Size
7.6 KB
Accession
0001562180-22-007408
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-01+64,410→ 64,410 totalExercise: $37.88Exp: 2032-11-01→ Common Stock (64,410 underlying)
Footnotes (1)
- [F1]The securities awarded on November 1, 2022 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 16,102 shares of common stock shall vest on the one year anniversary of October 31, 2022, with 48,308 shares vesting in 36 equal monthly installments thereafter.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001951944
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 5:30 PM ET
- Size
- 7.6 KB